These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9740134)

  • 1. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: introduction.
    Brandt JT
    Arch Pathol Lab Med; 1998 Sep; 122(9):765-6. PubMed ID: 9740134
    [No Abstract]   [Full Text] [Related]  

  • 2. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
    Olson JD; Arkin CF; Brandt JT; Cunningham MT; Giles A; Koepke JA; Witte DL
    Arch Pathol Lab Med; 1998 Sep; 122(9):782-98. PubMed ID: 9740136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of coagulation during treatment with direct oral anticoagulants].
    Kasper A; Lindhoff-Last E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
    [No Abstract]   [Full Text] [Related]  

  • 5. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
    Laposata M; Green D; Van Cott EM; Barrowcliffe TW; Goodnight SH; Sosolik RC
    Arch Pathol Lab Med; 1998 Sep; 122(9):799-807. PubMed ID: 9740137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory testing of anticoagulants: the present and the future.
    Favaloro EJ; Lippi G; Koutts J
    Pathology; 2011 Dec; 43(7):682-92. PubMed ID: 22081129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescription and monitoring of anticoagulant therapies].
    Laviolle B; Oger E
    Rev Prat; 2008 Nov; 58(18):2063-70. PubMed ID: 19143281
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. College of American Pathologists Conference XXVIII on alternate site testing: keynote address. Reflections on a C major scale.
    Woodruff KH
    Arch Pathol Lab Med; 1995 Oct; 119(10):876. PubMed ID: 7487380
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendation for the introduction of the International Normalized Ratio as an objective measure for the dosage of oral anticoagulant therapy].
    Horstkotte D; Hohnloser S; Keller F; Kolde HJ; Müller-Beissenhirtz W; Taborski U; Webering F
    Z Kardiol; 1994 Sep; 83(9):676-9. PubMed ID: 7801672
    [No Abstract]   [Full Text] [Related]  

  • 14. College of American Pathologists Conference XXVIII on alternate site testing: introduction.
    Handorf CR
    Arch Pathol Lab Med; 1995 Oct; 119(10):867-73. PubMed ID: 7487378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current considerations in the use of the APTT in monitoring unfractionated heparin.
    Nelson DE
    Clin Lab Sci; 1999; 12(6):359-64. PubMed ID: 10724634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A clinical perspective.
    Machin SJ
    Lab Hematol; 2004; 10(3):172-3. PubMed ID: 15529439
    [No Abstract]   [Full Text] [Related]  

  • 17. When should low-molecular-weight heparin be monitored?
    Fairweather RB
    CAP Today; 1999 Jul; 13(7):48-50. PubMed ID: 10558049
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulant therapy. What to consider in practical management.
    McPherson ML; Grace KA
    Adv Nurse Pract; 1997 May; 5(5):32-4, 37-9. PubMed ID: 9459911
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation monitoring.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):283-304. PubMed ID: 19665679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring anticoagulant therapy by measuring haemostatic parameters.
    Chek JB
    East Afr Med J; 1997 Jan; 74(1):1-2. PubMed ID: 9145566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.